Gain unprecedented insights from highly multiplexed single-cell spatial biology.

Advances in High-Parameter Cytometry and Imaging Mass Cytometry™

February 23, 2022

Cytometry by time-of-flight technology, used in CyTOF® systems, is now available at NYU Langone.

Revealing cellular variations in perceived homogeneous populations has become crucial to characterizing immune responses, understanding cancer cells, tracking stem cell lineage, and studying the effectiveness of biological therapies. Additionally, the need for antibody-based, high-parameter protein analysis is underscored by its capacity to identify rare and previously uncharacterized cell populations. This ability has far-reaching implications in both basic research and translational research.

Join the Cytometry and Cell Sorting Laboratory for a presentation on the principles of the Helios™ mass cytometry system and the utility of high-parameter analysis. The speakers will highlight research discoveries made possible with mass cytometry and the Hyperion™ Imaging System and its workflow, and outline some of the groundbreaking research enabled by Imaging Mass Cytometry™ (IMC™).

Speakers will include Andrew Draghi II, PhD, Field Applications Scientist, Fluidigm; Chiara Giannarelli, MD, PhD, Departments of Medicine and Pathology, NYULH; Hiran Ravichandran, MS, Research Associate, Weill Cornell Medicine.

Information in this publication is subject to change without notice. Limited Use Label License: The purchase of this Fluidigm Instrument and/or Consumable conveys to the purchaser the limited, nontransferable right to use with only with Fluidigm Consumables and/or Instruments respectively except as approved in writing by Fluidigm: Patents: Trademarks: Fluidigm, the Fluidigm logo, CyTOF, CyTOF XT, Helios and Hyperion are trademarks and/or registered trademarks of Fluidigm Corporation or its affiliates in the United States and/or other countries. All other trademarks are the sole property of their respective owners. © 2022 Fluidigm Corporation. All rights reserved. 2/2022